SAFE ORTHOPAEDICS SA (ALSAF.PA) Forecast, Price Target & Analyst Ratings
EPA:ALSAF • FR001400ZU25
Current stock price
0.8 EUR
-0.03 (-3.61%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SAFE ORTHOPAEDICS SA (ALSAF.PA).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of €0.80 to mean target of N/A, Based on 7 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
40.00%
ALSAF.PA was analyzed by 7 analysts. The buy percentage consensus is at 40. So analysts seem to be rather negative about ALSAF.PA.
In the previous month the buy percentage consensus was at a similar level.
ALSAF.PA was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates 2025
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|
| Revenue YoY % growth | 5.861M 28.70% | 5.81M -0.87% | 5.041M -13.24% | 8.858M 75.72% | |
| EBITDA YoY % growth | -5.003M 25.47% | -1.865M 62.72% | -1.904M -2.09% | -4.841M -154.25% | |
| EBIT YoY % growth | -5.962M 21.37% | -6.186M -3.76% | -2.247M 63.68% | -4.841M -115.44% | |
| Operating Margin | -101.72% | -106.47% | -44.57% | -54.65% | |
| EPS YoY % growth | N/A 38.89% | N/A 100.00% | N/A 41.67% | -0.06 14.29% |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A